How do you pay?

How to pay the least

Ask for the cash price

CombiPatch

No generic is sold yet.

  1. Ask your pharmacy for CombiPatch’s cash price, and one or two other pharmacies too.

Has to be CombiPatch? CombiPatch Savings Offer takes up to $75 off a prescription without insurance.

Sign up on combipatch.com 

Compare every option

Question
Brand nameCombiPatch
Authorized genericestradiol and norethindrone
Regular genericestradiol and norethindrone
What you’d pay
Up to$75 offa prescription from the maker
Not soldThere isn’t one
Not soldNone sold yet
Same as CombiPatch?
The original
–
–

Brand nameThe maker’s cash price

CombiPatch Savings Offer

Cash price from Noven Therapeutics

No insurance · up to $75 off a prescription

Sign up on combipatch.com 

Or call 1-833-483-2178.

In the maker’s words

“Patients receive $75 off their COMBIPATCH prescription…”

From the maker’s offer on combipatch.com, checked November 2, 2026. Check the maker’s page for who can use it.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s price above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is CombiPatch itself, from the same company, sold without the brand name, and usually for less. For now CombiPatch is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

CombiPatch is indicated in a woman with a uterus for:

  • Treatment of moderate to severe vasomotor symptoms due to menopause.
  • Treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause. When prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered.
  • Treatment of hypoestrogenism due to hypogonadism, castration, or primary ovarian failure.

Source: the FDA label for CombiPatch (Noven Therapeutics, LLC), February 21, 2024. Full label on DailyMed 

Good to know